Skip to main content

Complete Genomics, Inc. (NASDAQ:GNOM) Investor Files Lawsuit Against Takeover

  • If you purchased shares of the Complete Genomics, Inc. (NASDAQ:GNOM) prior to September 17, 2012, and currently hold any of those NASDAQ:GNOM , you shares have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

Sept. 28, 2012 (Shareholders Foundation) -- An investor in shares of Complete Genomics, Inc. (NASDAQ:GNOM) filed a lawsuit against directors of Complete Genomics in effort to block the proposed takeover at $3.15 per NASDAQ:GNOM. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:GNOM investors arising out of their attempt to sell the company too ...



You must register (for free) or login to view the entire case.